New nanotechnological therapy for Parkinson´s disease: nose to brain delivery of GBA-polymer nanoconjugates

Lorenzo Rivera, Julia (Principal Investigator)
Novio Vazquez, Fernando (Investigator)
Montpeyó Garcia Moreno, David (Collaborator)
Sarle Valles, Pau (Collaborator)
Pradas Gracia, Eddi (Collaborator)
Tanco , Sebastian Martin (Collaborator)

Description

Nanoconjugation of recombinant GBA as a new therapy in Parkinson’s
disease to restore neuronal GBA activity

Acronym	NANOGBAtoBRAIN
Status	Finished
Effective start/end date	1/11/22 → 30/06/26

Collaborative partners

Vall d'Hebron Research Institute (lead)
Príncipe Felipe Research Center (CIPF)

Funding

Obra Social la Caixa

1 Article

Systematic Assessment of Matrix Effect, Recovery, and Process Efficiency Using Three Complementary Approaches : Implications for LC-MS/MS Bioanalysis Applied to Glucosylceramides in Human Cerebrospinal Fluid
Castillo-Ribelles, L., Hernández-Vara, J., Ferrer Costa, R., Martinez-Vicente, M., Carnicer-Cáceres, C. & Arranz-Amo, J. A., 2025, In: ACS Omega. 10, p. 52449-52458 10 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

5 Link opens in a new tab Citations (Scopus)